US 9738726
HER2-specific monoclonal antibodies and conjugates thereof
granted A61KA61K2039/505A61K47/6811
Quick answer
US patent 9738726 (HER2-specific monoclonal antibodies and conjugates thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/505, A61K47/6811, A61K47/6829, A61K47/6851